Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 939
1.
BMJ Case Rep ; 17(4)2024 Apr 22.
Article En | MEDLINE | ID: mdl-38649247

Chondroid syringoma (CS) is a benign, slow-growing mixed tumour that arises from the sweat glands and usually presents in the head and neck area. Histopathological examination is important for proper diagnosis, as CS is often confused with epidermal cysts due to its rare presentation. This article presents a man in his 40s with a right upper lip mass that emerged 6 months prior to presentation. An intraoral surgical excision was performed and the histopathological analysis revealed solid epithelial cells that formed multiple, non-branching ducts lined by cuboidal epithelium. Cystic spaces were filled by heterogeneous eosinophilic material embedded in chondromyxoid stroma. Histopathology identified the lesion as an eccrine-variant CS. The patient recovered well.


Adenoma, Pleomorphic , Lip Neoplasms , Sweat Gland Neoplasms , Humans , Male , Adenoma, Pleomorphic/pathology , Adenoma, Pleomorphic/surgery , Adenoma, Pleomorphic/diagnosis , Adenoma, Pleomorphic/diagnostic imaging , Sweat Gland Neoplasms/pathology , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/diagnosis , Lip Neoplasms/pathology , Lip Neoplasms/diagnosis , Lip Neoplasms/surgery , Adult , Diagnosis, Differential , Lip/pathology , Lip/surgery , Eccrine Glands/pathology
2.
Medicine (Baltimore) ; 103(13): e37607, 2024 Mar 29.
Article En | MEDLINE | ID: mdl-38552084

RATIONALE: This article presents a challenging case involving an elderly male patient with a misdiagnosed intraductal mammary papilloma initially identified as a sweat adenoma through ultrasound imaging. The study aims to explore the histopathology, clinical presentations, and sonographic features of both conditions, emphasizing the contributing factors to the diagnostic misstep. PATIENT CONCERNS: A 61-year-old male reported a persistent left breast mass, along with pain and swelling, spanning a 6-month duration. DIAGNOSES: Ultrasound examination indicated a deep, square, mixed-echo mass in the left nipple, initially suggestive of a sweat adenoma. However, subsequent pathological analysis following resection under general anesthesia confirmed an intraductal papilloma. INTERVENTION: The patient underwent surgical resection of the left breast mass under general anesthesia. OUTCOME: Post-surgery, the patient exhibited satisfactory recovery; however, regrettably, he was lost to follow-up. LESSONS: This study underscores the challenge in differentiating between clear cell sweat adenoma and male intraductal mammary papilloma solely based on ultrasonic characteristics. It emphasizes the susceptibility of ultrasound-based diagnoses to misinterpretation, highlighting the critical need for a comprehensive pathological examination to establish a definitive diagnosis.


Acrospiroma , Breast Neoplasms , Papilloma, Intraductal , Papilloma , Sweat Gland Neoplasms , Male , Humans , Aged , Middle Aged , Acrospiroma/pathology , Papilloma, Intraductal/diagnosis , Papilloma, Intraductal/surgery , Papilloma, Intraductal/pathology , Breast Neoplasms/pathology , Nipples/pathology , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology , Papilloma/pathology
3.
Dermatol Surg ; 50(6): 507-511, 2024 Jun 01.
Article En | MEDLINE | ID: mdl-38460197

BACKGROUND: Hidradenocarcinoma (HAC) is a rare adnexal carcinoma. To the best of the authors' knowledge, there are no published systematic reviews on HAC. OBJECTIVE: To incorporate a case series from the authors' institution and systematically integrate reported information to provide a reference tool for optimization of diagnosis and management. METHODS: A comprehensive MEDLINE search was conducted from database inception to 2021 using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. This yielded 225 studies with 165 cases of HAC. References of included articles were also searched. In addition, 9 patients with HAC were identified from the authors' institution over the past 10 years. RESULTS: The mean age of HAC presentation is 60 years with a slight male predilection (60%). The head and neck is the most commonly affected region. Over 36% of cases either presented with metastatic disease or went on to metastasize. The most common treatment type was wide local excision, followed by Mohs micrographic surgery. CONCLUSION: Early detection with accurate histologic interpretation is prudent in all cases of HAC. Wide local excision is the current first-line treatment. However, Mohs micrographic surgery offers complete marginal analysis with evidence of reduced risk of metastasis and better outcomes compared with wide local excision. Currently, there are no National Comprehensive Cancer Network guidelines for the treatment of HAC, and consensus guidelines are limited to tumor and nodal metastasis staging provided by the American Joint Committee on Cancer, eighth edition. Thus, this case series and systematic review integrates important aspects of diagnosis, workup, and management of HAC.


Mohs Surgery , Sweat Gland Neoplasms , Female , Humans , Male , Middle Aged , Acrospiroma/pathology , Acrospiroma/diagnosis , Acrospiroma/surgery , Sweat Gland Neoplasms/pathology , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/therapy
7.
Am J Case Rep ; 24: e941975, 2023 Dec 20.
Article En | MEDLINE | ID: mdl-38115572

BACKGROUND Eyelid tumors belong to a diverse group of neoplasms ranging from benign lesions to malignant tumors. Poromas are common, benign, mostly unpigmented tumors of the epidermal sweat duct unit, that usually grow slowly and occur in elderly people on the palms and soles. In most poroma cases some gene fusions were detected, which were caused by chromosomal aberrations. CASE REPORT We report the atypical case of a 30-year-old female patient suffering for more than 15 years from a solitary, polypoid, pigmented formation with a focal tuberous surface on the left lower eyelid. The lesion was not growing during the first years, but in the last 6 months before diagnosis its size more than doubled, finally reaching 12×14 mm. It was removed and histopathological analysis confirmed the diagnosis of a rare tumor - a poroma. There were no complications during healing and no recurrence was reported. CONCLUSIONS There have so far been only 9 reports of eyelid poromas, and the presented case significantly differed from the previous ones, as it appeared at an early age and showed rapid growth during a short time due to the war-related acute psychological stress. Moreover, it had unusual pigmentation and unpleasant smell. Reporting such untypical cases is clinically important because it is crucial to be aware of the diversity of eccrine poroma manifestation to distinguish it from malignant lesions.


Pigmentation Disorders , Poroma , Sweat Gland Neoplasms , Adult , Female , Humans , Diagnosis, Differential , Eyelids , Poroma/diagnosis , Poroma/pathology , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology
8.
BMJ Case Rep ; 16(10)2023 Oct 24.
Article En | MEDLINE | ID: mdl-37879716

A rare case of pericanalicular eccrine hidrocystoma of the upper eyelid is reported in a child who underwent surgical excision and canalicular repair with a successful outcome.


Eyelid Neoplasms , Hidrocystoma , Lacrimal Apparatus , Sweat Gland Neoplasms , Humans , Child , Hidrocystoma/diagnosis , Hidrocystoma/surgery , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/surgery , Eyelids/surgery
10.
Cutis ; 112(3): E6-E10, 2023 Sep.
Article En | MEDLINE | ID: mdl-37903397

Endocrine mucin-producing sweat gland carcinoma (EMPSGC) and primary cutaneous mucinous carcinoma (PCMC) are rare low-grade neoplasms thought to arise from apocrine glands that share many histological features and are proposed to be on a single histopathologic continuum, with EMPSGC as the in situ form that may progress to the invasive PCMC. Management involves a metastatic workup and either wide local excision (WLE) with greater than 5 mm margins or Mohs micrographic surgery (MMS) in anatomically sensitive areas. We present 2 cases of EMPSGC and 3 cases of PCMC and review their clinical and histopathologic features, differential diagnoses, and treatment.


Adenocarcinoma, Mucinous , Carcinoma, Skin Appendage , Skin Neoplasms , Sweat Gland Neoplasms , Humans , Adenocarcinoma, Mucinous/diagnosis , Adenocarcinoma, Mucinous/surgery , Adenocarcinoma, Mucinous/pathology , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/surgery , Skin Neoplasms/pathology , Sweat Glands/pathology , Mucins
11.
Acta Dermatovenerol Croat ; 31(1): 36-39, 2023 Aug.
Article En | MEDLINE | ID: mdl-37843089

Primary cutaneous apocrine carcinoma (PCAC), a subtype of sweat gland carcinoma, is an extremely rare malignant neoplasm. Distinguishing an apocrine carcinoma from a breast carcinoma metastasis is difficult even for a pathologist. Most arise in regions of high apocrine gland density like the axilla, and rarely on the scalp and eyelid, but they can occur elsewhere on the skin. Primary cutaneous apocrine carcinoma of the scalp is a rare malignancy most often reported in the literature as case reports or small case series. The giant form of primary cutaneous apocrine carcinoma in the frontal region has not been described in the literature, to the best of our knowledge. There are no established protocols for treatment of primary cutaneous apocrine carcinoma. We report a case of a giant primary cutaneous apocrine carcinoma localized in the frontal region. A definitive diagnosis of a primary cutaneous apocrine carcinoma was established by biopsy with microscopic and immunohistochemical analysis. Wide surgical excision and reconstruction with large local transposition flap and split thickness skin grafts for secondary defect were our therapy of choice. Primary cutaneous apocrine carcinoma is a very rare malignancy, and the giant form has not yet been described. Surgical treatment provided the patient with tumor-free status as well as satisfactory aesthetical appearance and quality of life.


Breast Neoplasms , Carcinoma , Sweat Gland Neoplasms , Humans , Female , Quality of Life , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology , Melanoma, Cutaneous Malignant
13.
Am J Surg Pathol ; 47(12): 1409-1416, 2023 12 01.
Article En | MEDLINE | ID: mdl-37737683

Spiradenomas are benign cutaneous adnexal neoplasms with sweat gland differentiation that can manifest a broad spectrum of histomorphologic appearances. While they show a characteristic histopathologic phenotype and clinical management involves surgical excision with a low risk of recurrence, there have been unusual histopathologic variants of spiradenoma reported, including cases with adenoid cystic carcinoma (ACC)-like changes. Primary cutaneous ACC is a low-grade malignancy presenting as a subcutaneous mass with the potential for local invasion, perineural invasion, and high rates of local recurrence after excision. The diagnosis of spiradenomas with ACC-like features can be challenging, especially when only the ACC-like component is present for evaluation. A retrospective analysis of 21 cases of spiradenoma with ACC-like changes were obtained from large academic institutions, was performed, and summarized below. All cases showed background of conventional spiradenoma, and the ACC-like areas represented a component in all lesions. The percentage of ACC-like component ranged from 5% to 40% in all cases. The ACC-like component was multifocal and without pleomorphism, perineural and/or vascular invasion, necrosis, or increased mitotic activity. MYB translocation and protein expression was studied in 16 cases by fluorescence in situ hybridization, polymerase chain reaction, and immunohistochemistry. All studied cases were negative for MYB / NFIB , MYB L1, and MYB F by fluorescence in situ hybridization and polymerase chain reaction and 3 cases were positive for MYB expression by immunohistochemistry. Our study expands on spiradenomas with ACC-like features that ought to be considered in the differential diagnosis of cutaneous neoplasms such as primary cutaneous ACC. Our results indicate that a thorough histopathologic inspection and strict application of well-defined histologic criteria are necessary to support the diagnosis of this unusual histopathologic variant. These tumors can be difficult to diagnose, and awareness of their histomorphologic spectrum will facilitate definitive diagnosis and avoid misdiagnosis with other conditions.


Acrospiroma , Carcinoma, Adenoid Cystic , Skin Neoplasms , Sweat Gland Neoplasms , Humans , Carcinoma, Adenoid Cystic/pathology , Acrospiroma/surgery , In Situ Hybridization, Fluorescence , Retrospective Studies , Skin Neoplasms/pathology , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology
14.
Article En | MEDLINE | ID: mdl-37715975

Eccrine porocarcinoma is a rare malignant tumor of the eccrine sweat gland. This malignancy occurs most commonly in the lower extremities. It tends to occur in patients aged 60 to 80 years, affecting men and women equally. We present the case of a 62-year-old man with a lesion on the left foot. The diagnosis of the initial biopsy was squamous cell carcinoma. Six months later, the lesion reoccurred, and a second biopsy confirmed it to be eccrine porocarcinoma.


Eccrine Porocarcinoma , Sweat Gland Neoplasms , Humans , Male , Middle Aged , Biopsy , Eccrine Glands/pathology , Eccrine Porocarcinoma/diagnosis , Eccrine Porocarcinoma/surgery , Eccrine Porocarcinoma/pathology , Foot/pathology , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology
16.
Eur J Dermatol ; 33(3): 241-244, 2023 Jun 01.
Article En | MEDLINE | ID: mdl-37594329

BACKGROUND: Hidradenocarcinoma is a rare malignant sweat gland tumour, characterized by a slow but aggressive course, with high rates of local recurrence and metastasis. Due to its rarity, histological criteria and therapeutic guidelines are poorly defined, posing a major challenge for clinicians and pathologists. OBJECTIVES: To present two new cases of metastatic hidradenocarcinoma as well as a review of the literature. MATERIALS & METHODS: We describe two case studies and a review of the literature based on a search using the MEDLINE (PubMed) electronic database. RESULTS: The first patient was a 61-year-old woman with a perimamillary hidradenocarcinoma that arose from the malignant transformation of a benign childhood lesion and developed regional lymph node metastases after wide excision and adjuvant radiotherapy. The second patient was a 63-year-old man who developed cutaneous and renal metastases several years after the complete excision of a lumbar hidradenocarcinoma. As far as we can ascertain, kidney metastasis from hidradenocarcinoma has not previously been described. CONCLUSION: Most authors recommend wide excision as the treatment of choice for hidradenocarcinoma, however, optimal adjuvant therapy remains to be determined. Our cases add to the limited knowledge available, but high-quality studies to find new effective treatments are needed.


Carcinoma, Skin Appendage , Kidney Neoplasms , Skin Neoplasms , Sweat Gland Neoplasms , Male , Female , Humans , Child , Middle Aged , Sweat Gland Neoplasms/surgery , Combined Modality Therapy , Databases, Factual
17.
Ophthalmic Plast Reconstr Surg ; 39(6): e199-e202, 2023.
Article En | MEDLINE | ID: mdl-37486338

The authors present the third example of an eccrine ductal carcinoma of the eyelid. A woman in her early 70s presented with a lesion of the central right lower eyelid margin in the vicinity where an actinic keratosis was diagnosed by biopsy 2.75 years previously. Her dermatologist and ophthalmologist monitored the area of actinic keratosis, and it was stable for 2.5 years until the area became ulcerated and thickened with the loss of eyelashes. A wedge resection disclosed a squamous cell carcinoma in situ and a separate eccrine ductal carcinoma. The eccrine ductal carcinoma had in situ tumor thickening, an eccrine duct component, and an invasive tumor infiltrating the tarsal plate and replacing the normal meibomian glands. The invasive eccrine ductal carcinoma only mildly thickened the tarsal plate and was most likely an incidental finding in a biopsy prompted by the squamous cell carcinoma in situ. The 5-year relative survival rate for malignant apocrine-eccrine tumors is approximately 97%, and our patient is alive and without evidence of local or distant tumor recurrence 5.5 years following the excision of her eyelid tumor.


Carcinoma, Ductal , Carcinoma, Squamous Cell , Keratosis, Actinic , Sweat Gland Neoplasms , Humans , Female , Keratosis, Actinic/pathology , Neoplasm Recurrence, Local/pathology , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology , Carcinoma, Squamous Cell/pathology , Meibomian Glands/pathology , Carcinoma, Ductal/pathology , Eccrine Glands/pathology
18.
Acta Derm Venereol ; 103: adv11649, 2023 Jul 13.
Article En | MEDLINE | ID: mdl-37448211

Eccrine porocarcinoma is a rare skin adnexal tumour that affects elderly people. Most eccrine porocarcinomas are stage I or II according to the American Joint Committee on Cancer. The prognosis is good in early stages, but worsens when advanced. Since information on the use of sentinel lymph node biopsy in these patients is scarce, this study examined the records of all patients with eccrine porocarcinoma treated at Helsinki University Hospital during a 17-year period and focused on sentinel lymph node biopsy patients. The study identified 14 patients (9 male, 5 female). There were 2 metastases to the lymph nodes and 2 recurrences at initial referral to our institution. All primary tumours had wide local excision and 6 patients also had sentinel lymph node biopsy, of whom none had positive lymph nodes. There were no new metastases or recurrences during follow-up. Three patients died of causes other than eccrine porocarcinoma. When comparing the wide local excision only and wide local excision with sentinel lymph node biopsy groups, no parameters reached statistical significance. The decision process of the multidisciplinary tumour board meeting on whether to perform sentinel lymph node biopsy was not clear, perhaps due to the limited knowledge of eccrine porocarcinoma. Further studies and international collaboration are warranted.


Eccrine Porocarcinoma , Sentinel Lymph Node , Sweat Gland Neoplasms , Humans , Male , Female , Aged , Eccrine Porocarcinoma/surgery , Eccrine Porocarcinoma/pathology , Sentinel Lymph Node/pathology , Sweat Gland Neoplasms/surgery , Sweat Gland Neoplasms/pathology , Sentinel Lymph Node Biopsy , Lymph Node Excision , Lymph Nodes/pathology , Recurrence
19.
Article En | MEDLINE | ID: mdl-37463189

Although chondroid syringoma rarely occurs outside the head and neck, the majority of malignant chondroid syringomas are identified in the extremities. Here, we present a case of atypical chondroid syringoma in the fifth toe. Diagnosis of chondroid syringoma with atypical cells was made following initial excisional biopsy and histology, necessitating repeated surgery for positive margins. In this case report, we examine the radiopathologic correlation of this diagnosis, detail the imaging findings of benign and malignant chondroid syringomas, and highlight how magnetic resonance imaging can be used to guide surgical planning and treatment course of this potentially malignant tumor.


Adenoma, Pleomorphic , Sweat Gland Neoplasms , Humans , Adenoma, Pleomorphic/diagnostic imaging , Adenoma, Pleomorphic/surgery , Sweat Gland Neoplasms/diagnostic imaging , Sweat Gland Neoplasms/surgery , Biopsy , Reoperation
...